Clinical Trials Logo

Clinical Trial Summary

After preterm prelabor rupture of membranes (PPROM)[breaking of the amniotic sac prior to 37 weeks gestation in pregnancy], patients are recommended for inpatient admission and close monitoring for complications including preterm labor, intraamniotic infection (infection of the sac around the baby), and placental abruption (separation of the placenta from wall of the uterus). When evaluation of cervical dilation is clinically indicated, obstetricians traditionally perform sterile speculum exams due to concern for decrease in pregnancy latency (length of time between breaking the water and delivery) with sterile digital exams in retrospective studies. These studies are concerning, however, by the indications for the exams and are at risk for confounding by indication. This is a randomized, non-inferiority trial to examine if sterile digital versus speculum exams effect latency of pregnancy in patients with PPROM.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Fetal Membranes, Premature Rupture
  • PPROM

NCT number NCT05773014
Study type Interventional
Source Washington University School of Medicine
Contact Julia Burd, MD
Phone (314) 362-7135
Email burd.j@wustl.edu
Status Recruiting
Phase N/A
Start date March 27, 2023
Completion date January 1, 2025

See also
  Status Clinical Trial Phase
Terminated NCT02939742 - Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? Phase 2/Phase 3
Recruiting NCT05322252 - Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial Phase 4
Not yet recruiting NCT02069587 - Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes N/A
Recruiting NCT06443788 - Trans-perineal Ultrasound in Assessment of PPROMs N/A
Recruiting NCT03819192 - Predicting EONS in PPROM Patients
Not yet recruiting NCT03739463 - Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity N/A